DatFlash Logo
DatFlashTM tracks real-world dataset transactions and supply signals, normalized for AI decision-making.

Multimodal records from Tempus’s de-identified oncology dataset

Price
$1,375,000
Date
2026-10-14
Buyer
Bristol Myers Squibb
Seller
Tempus AI
Type
Region
United States/Global
Market Context
BMS may use the licensed oncology records with Pathos AI’s Foundry drug-development platform. It may terminate with 12 months’ notice, but must pay a substantial termination fee whose amount remains undisclosed. Calculated valuation signal: Approximately $27.5 million per year over a nominal five-year period. This is an estimate because the exact commencement period and quarterly payment allocation were not disclosed.
Term
Annual  (5 years)
Confidence: High
Citation: DatFlash (2026). "Multimodal records from Tempus’s de-identified oncology dataset"
https://www.datflash.com/transaction/bristol-myers-squibb-tempus-ai
Download JSON